A medication that has been ingested alters chemically and metabolically. The medicine is now less readily available at the body's ultimate site of action as a result of these modifications. For instance, some medications may not be productive when taken orally but may be useful when given intravenously. The optimal method of drug delivery helps to achieve the medicine's full therapeutic benefit by reducing or avoiding these alterations. Additionally, when given through a specific route as opposed to another, some medications are more fully absorbed. 100% bioavailability is achieved when the medication is administered intravenously. There are various factors that influence a drug's preferred method of administration. These include drug characteristics, the targeted location of action, the rate and amount of absorption from the drug administration site, and the drug administration site itself. The effect of digestive juices and first pass metabolism, the speed with which the required reaction is achieved in an emergency or during normal therapy, the need for precise dosing, the patient's condition and compliance. The Various routes of Drug Administration includes:
1. Gastrointestinal route
a) Oral route
b) Sublingual route
c) Buccal route
d) Rectal route
2. Parenteral route
a) Intradermal
b) Sub-cutaneous
c) Intramuscular
d) Intravenous
3.Topical route
a) Transdermal patches
b) Instillations
c) Irrigation or Douching
d) Epidermic and enepidermic routes
e) Throat paints
4. Inhalation route
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia